José González

1.1k total citations
25 papers, 507 citations indexed

About

José González is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, José González has authored 25 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Hematology. Recurrent topics in José González's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). José González is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). José González collaborates with scholars based in Spain, United States and Uruguay. José González's co-authors include Pau Montesinos, Elena de Lisa, Miguel Á. Sanz, Josep‐María Ribera, Javier de la Serna, Gert J. Ossenkoppele, Juan Bergua, Salut Brunet, Bob Löwenberg and Chelo Rayón and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

José González

23 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José González Spain 10 365 297 99 76 72 25 507
P. Flynn United States 6 178 0.5× 135 0.5× 82 0.8× 29 0.4× 29 0.4× 12 320
Isabelle Luquet France 13 195 0.5× 499 1.7× 88 0.9× 62 0.8× 14 0.2× 45 636
Maoxiang Qian China 11 315 0.9× 189 0.6× 118 1.2× 93 1.2× 9 0.1× 43 516
Shane G. Supple Australia 5 79 0.2× 66 0.2× 45 0.5× 37 0.5× 10 0.1× 6 224
Ming Hou China 14 188 0.5× 216 0.7× 70 0.7× 39 0.5× 6 0.1× 31 461
Masakazu Sawanobori Japan 9 97 0.3× 166 0.6× 46 0.5× 39 0.5× 47 0.7× 17 357
Mark S. Brower United States 7 106 0.3× 228 0.8× 37 0.4× 98 1.3× 23 0.3× 10 422
Amer M. Zeidan United States 7 378 1.0× 493 1.7× 160 1.6× 94 1.2× 3 0.0× 21 729
Darren Evanchuk United States 5 132 0.4× 268 0.9× 94 0.9× 11 0.1× 53 0.7× 7 548
R. C. Horns United States 6 159 0.4× 67 0.2× 176 1.8× 65 0.9× 3 0.0× 11 411

Countries citing papers authored by José González

Since Specialization
Citations

This map shows the geographic impact of José González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José González more than expected).

Fields of papers citing papers by José González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José González. The network helps show where José González may publish in the future.

Co-authorship network of co-authors of José González

This figure shows the co-authorship network connecting the top 25 collaborators of José González. A scholar is included among the top collaborators of José González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José González. José González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carbonell‐Asins, Juan Antonio, Carolina Martínez‐Ciarpaglini, José González, et al.. (2025). Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations. ESMO Open. 10(10). 105771–105771.
2.
Martín-Martorell, Paloma, Francisco Aparisi, María José Domper-Arnal, et al.. (2024). A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations. Clinical & Translational Oncology. 27(6). 2568–2578. 1 indexed citations
3.
González, José, Beatriz Sánchez‐Sendra, & Carlos Monteagudo. (2023). Diagnostic Algorithm to Subclassify Atypical Spitzoid Tumors in Low and High Risk According to Their Methylation Status. International Journal of Molecular Sciences. 25(1). 318–318.
4.
Monteagudo, Carlos, Beatriz Sánchez‐Sendra, José González, et al.. (2021). Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations. The American Journal of Surgical Pathology. 45(10). 1382–1390. 4 indexed citations
5.
Burillo‐Sanz, Sergio, María Teresa Vargas, Teresa Caballero‐Velázquez, et al.. (2020). ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype. Cancer Medicine. 9(11). 3637–3646. 13 indexed citations
6.
Sánchez‐Sendra, Beatriz, Eva Serna, Lara Navarro, et al.. (2020). Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma. Scientific Reports. 10(1). 4771–4771. 10 indexed citations
7.
Martínez‐Ciarpaglini, Carolina, Sara S. Oltra, Susana Roselló, et al.. (2018). Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression. Modern Pathology. 32(2). 306–313. 33 indexed citations
8.
Falantes, José, Francisco J. Márquez‐Malaver, Cristina Calderón‐Cabrera, et al.. (2018). Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 18(7). 469–474.e1. 2 indexed citations
9.
Sánchez‐Sendra, Beatriz, et al.. (2018). Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival. Scientific Reports. 8(1). 17076–17076. 22 indexed citations
10.
Barba, Pere, Rodrigo Martino, David Martínez‐Cuadrón, et al.. (2015). Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia. Leukemia & lymphoma. 56(10). 2812–2818. 3 indexed citations
11.
Falantes, José, José I. Piruat, Francisco J. Márquez‐Malaver, et al.. (2014). Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 15(4). 236–244. 28 indexed citations
12.
Falantes, José, Francisco J. Márquez‐Malaver, M.L. Martino, et al.. (2012). Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories. Clinical Lymphoma Myeloma & Leukemia. 13(2). 144–152. 13 indexed citations
13.
González, José, et al.. (2012). Septal dissection after inferior acute myocardial infarction. Dialnet (Universidad de la Rioja). 80(4). 2 indexed citations
14.
Gucalp, Ayca, SM Tolaney, SJ Isakoff, et al.. (2011). TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).. Journal of Clinical Oncology. 29(15_suppl). TPS122–TPS122. 4 indexed citations
15.
Barba, Pere, Antònia Sampol, María Calbacho, et al.. (2011). Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience. Blood. 118(21). 4246–4246. 1 indexed citations
16.
17.
González, José, et al.. (1998). Vascular enumeration as a significant prognosticator for invasive breast carcinoma.. Journal of Clinical Oncology. 16(5). 1684–1688. 35 indexed citations
18.
González, José, et al.. (1998). Portal hypertensive colopathy: histologic appearance of the colonic mucosa.. PubMed. 45(19). 40–3. 8 indexed citations
19.
Ladero, J. M., et al.. (1991). Acetylator polymorphism in human colorectal carcinoma.. PubMed. 51(8). 2098–100. 55 indexed citations
20.
González, José, et al.. (1989). [Angiodysplasia of the terminal ileum].. PubMed. 75(2). 179–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Flynn Breakdown of academic impact, for papers by Isabelle Luquet Breakdown of academic impact, for papers by Maoxiang Qian Breakdown of academic impact, for papers by Shane G. Supple Breakdown of academic impact, for papers by Ming Hou Breakdown of academic impact, for papers by Masakazu Sawanobori Breakdown of academic impact, for papers by Mark S. Brower Breakdown of academic impact, for papers by Amer M. Zeidan Breakdown of academic impact, for papers by Darren Evanchuk Breakdown of academic impact, for papers by R. C. Horns
Rankless by CCL
2026